Regulation of adrenocortical function by vasopressin

Hormone and Metabolic Research

Volumn 30, Issue 6-7, 1998, Pages 360-367

  Gallo Payet, N ^a,c   Guillon, G ^b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b CCIPE   (France)

^c UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Chromaffin Cells; Fasciculata Cells; Glomerulosa Cells; Vasopressin Receptors

Indexed keywords

VASOPRESSIN; VASOPRESSIN RECEPTOR;

ADRENAL CORTEX; ANIMAL TISSUE; ARTICLE; CHROMAFFIN CELL; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; ZONA FASCICULATA; ZONA GLOMERULOSA;

ANIMALIA;

EID: 0031749407     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978899     Document Type: Article

References (84)

1. Sofroniew MV. Vasopressin, oxytocin and their related neurophysins. In: Handbook of Chemical Neuroanatomy. Bjorklund A, Hökfelt T, editors. Amsterdam: Elsevier. 1985: 93-165
2. Sawchenko PE, Swanson LW, Vale WW. Coexpression of corticotropin releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of adrenalectomised rat. Proc Natl Acad Sci USA 1984; 81: 1883-7
3. Eckland DJA, Todd K, Lightman SL. Immunoreactive vasopressin and oxytocin in hypothalamo-hypophyial portal blood of the Brattleboro and Long Evans rat: Effect of adrenalectony and dexamethasone. J Endocrinol 1988; 117: 27-34
4. Antoni F. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 1986; 7: 351-78
5. Jard S. Vasopressin isoreceptors in mammals: relation to cyclic AMP-dependent and cyclic AMP independent transduction mechanisms. Curr Top Membr Transp 1983; 1: 225-85
6. Jard S, Elands J, Schmidt A, Barberis C. Vasopressin and oxytocin receptors In: Progress in Endocrinology. Imura H, Shizurne K, editors. Amsterdam: Excerpta Medica. 1988: 1183-8
7. Laszlo FA, Laszlo F, De Wied D. Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol Rev 1991; 43: 73-108
8. Grazzini E, Durroux T, Payet M-D, Bilodeau L, Gallo-Payet N, Guillon G. Membrane-delimited G protein mediated-coupling between V1 a vasopressin receptor and dihydropyridine binding sites in rat glomerulosa cells. Mol Pharmacol 1997; 50: 1273-83
9. Antoni FA, Holmes MC, Makara GB, Karteszi M, Laszlo FA. Evidence that the effects of arginine-8-vasopressin (AVP) on puitary corticotropin (ACTH) release are mediated by a novel type of receptor. Peptides 1984; 4: 519-22
10. Antoni FA. Novel ligand specificity of pituitary vasopressin receptors in the rat. Neuroendocrinology 1984; 39: 186-8
11. Jard S, Gaillard R, Guillon G, Marie J, Schoenenberg P, Muller AF, Manning M, Sawyer WH. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol 1986; 30: 171-7
12. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem 1994; 269: 27088-92
13. 3H]-vasopressin binding to isolated rat hepatocytes and liver membranes: Regulation by GTPand relation to glycogen phosphorylase activation. J Recept Res 1980; 1: 137-68
14. Schmidt A, Audigier S, Barberis C, Jard S. A radioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1 a receptor. FEBS Lett 1991; 282: 77-81
15. Saito M, Sugimoto T, Tahara A, Kawashima H. Molecular cloning and characterization of rat V1b vasopressin receptor: evidence for its expression in extra-pituitary tissues. Biochem Biophys Res Commun 1995; 212: 751-7
16. Lolait SJ, Ocarroll AM, Mahan LC, Felder CC, Button DC, Young WS, Mezey E, Brownstein MJ. Extrapituitary expression of the V1b vasopressin receptor gene. Proc Natl Acad sci USA 1995; 92: 6783-7
17. Nussdorfer G. Paracrine control of adrenal cortical functions by medullary chromaffin cells. Pharmacol Rev 1996; 48: 495-530.
18. Hilton JG, Scian LF, Westermann CD, Kruesi OR. Effect of synthetic lysine vasopressin on adrenocortical secretion. Science 1959; 129: 971
19. Hilton JG. Adrenocoticotropin action of antidiuretic hormone. Circulation 1960; 21: 1038-47
20. Payet N, Isler H. Adrenal glomerulosa mitotic stimulation by posterior pituitary hormones. Cell Tissue Res 1976; 172: 93-101
21. Payet N, Lehoux J. A comparative study of the role of vasopressin and ACTH in the regulation of growth and function of rat adrenal glands. J Steroid Biochem 1979; 12: 461-7
22. Ang VJY, Jenkins JS. Neurohypophysial hormones in the adrenal medulla. J Clin Endocrinol Metabolism 1984; 58: 688-91
23. Isler H. Effect of posterior pirtuitary powder on the mitotic activity of the zona glomerulosa of the adrenal glands in intacts and in hypophysectomized erats: a preliminary observation. Anat Rec 1973; 177: 321-4
24. Sarria R, Losada J, Bueno-Lòpez JL. Immunohistochemical analysis of adrenal proliferation and corticosterone expresion in experimental adrenal regeneration. Histol Histopathol 1995; 10: 603-9
25. Mitani F, Suzuki H, Hata J-I, Ogishima T, Shimada H, Ishimura Y. A novel cell layer without corticosteroid-synthesizing enzymes in rat adrenal cortex: Histochemical detection and possible physiological role. Endocrinology 1994; 135: 431-8
26. Payet N, Deziel Y, Lehoux J. Vasopressin: a potent growth factor in adrenal glomerulosa cells in culture. J Steroid Biochem 1984; 20: 449-54
27. Lesniewska B, Novawak M, Miskowiak B, Nussdorfer GG, Malendowicz LK. Effects of arginine-vasopressin on the pituitary-adrenocortical axis of intact and dexamethasone-suppressed rats. Exp Pathol 1991; 43: 181-8
28. Lesniewska B, Nussdorfer GG, Nowak M, Malendowicz LK. Comparison of the effects of neurotensin and vasopressin on the adrenal cortex of dexamethasone-suppressed rats. Neuropeptides 1992; 23: 9-13
29. Mazzochi G, Malendowicz L, Meneghelli V, Gottardo G, Nussdorfer G. In vitro and in vivo studies of the effects of arginine-vasopressin on the secretion and growth of rat adrenal cortex. Histol Histopathol 1995; 10: 359-70
30. Rozengurt E, Legg A, Pettican P. Vasopressin stimulation of mouse 3 T3 cell growth. Proc Natl Acad Sci USA 1979; 76: 1284-7
31. Marino M, Mangiantini MT, Spagnaolo S, Luly P, Leoni S. Signal transduction during liver regeneration: Role of insulin and vasopressin. J Cell Physiol 1992; 152: 403-9
32. Palkovits M, DeJong W, De Wield D. Hypothalamic control of aldosterone production in sodium-deficient rats. Neuroendocrinology 1974; 14: 297-309
33. Laulin JP, Simonnet G, Brudieux R, Carayon A, Vincent JD. Aldosterone secretion and adrenal angiotensin II receptors in the Brattleboro rat.J Endocrinol 1988; 117: 215-21
34. Brooks VL, Blakemore LJ. Vasopressin: a regulator of adrenal glucocorticoid production? Am J Physiol 1989; 256: E566-72
35. Laulin JP, Brudieux R. Atrial natriuretic factor is unlikely to be involved in the reduced aldosterone production in the Brattleboro rat. Regul Pept 1990; 31: 157-65
36. Yamlahi BE, Laulin JP, Brudieux R. Effect of sodium deprivation on plasma and adrenal concentrations of aldosterone and corticosterone in the Brattleboro homozygous rat. Exp Clin Endocrinol 1990; 96: 260-8
37. Scaccianoce S, Muscolo LAA, Cigliana G, Navarra D, Nicolai R, Angelucci L. Evidence for a specific role of vasopressin in sustaining pituitary-adrenocortictropin stress response in the rat. Endocrinology 1991; 128: 3138-43
38. Gillies G, Lowry P. Corticotrophin releasing factor may be modulated by vasopressin. Nature 1979; 278: 463-4
39. Hensen J, Hader O, Bähr V, Oelkers W. Effects of incremental infusions of argininin vasopressin on adrenocorticotropin and cortisol secretion in man. J Clin Endocrinol Metab 1988; 66: 668-71
40. Hinson J, Vinson G, Porter ID, Whitehouse B. Oxytocin and arginine vasopressin stimulate steroid secretion by the isolated perfused rat adrenal gland. Neuropeptides 1987; 10: 1-7
41. Guillon G, Trueba M, Grazzini E, Chouinard L, Coté M, Payet M, Manzoni O, Barberis C, Joubert DMR, Gallo-Payet N. Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin II effect. Endocrinology 1995; 136: 1285-95
42. Schneider E. Effect of vasopressin on adrenal steroidogenesis. Am J Physiol 1988; 255: R806-11
43. Pradier P, Davicco MJ, Safwate A, Tournaire C, Dalle M, Barlet JP, Delost P. Plasma adrenocorticotrophin, cortisol and aldosterone responses to ovine corticotrophin-releasing factor and vasopressin in sheep. Acta Endocrinologica 1986; 111: 93-100
44. Bird IM, Nicol M, Williams BC, Walker SW. Vasopressin stimulates cortisol secretion and phosphoinositide catabolism in cultured bovine adrenal fasciculata/reticularis cells. J Mol Endocrinol 1990; 5: 109-16
45. Pradier P, Dalle M. Effects of corticotrophin-releasing factor and vasopressin on plasma adrenocorticotrophin molecular forms, aldosterone and corticosterone in young and adult rats and rabbits. Reprod Fertil Dev 1996; 8: 111-6
46. Larcher A, Delarue C, Idres S, Lefebvre H, Feuillolley M, Vandesande F, Pelletier G, Vaudry H. Identification of vasotocin-like immunoreactivity in chromaffin cells of the frog adrenal gland: effect of vasotocin on corticosteroid secretion. Endocrinology 1989; 125: 2691-700
47. Iwamuro S, Hayashi H, Yamashita M, KiKuyama S. Arginine vasotocin (AVT) and AVT-related peptides are major aldosterone-releasing factors in the Bullfrog neurointermediate lobe. Gen Comp Endocrinol 1991; 84: 412-8
48. Bird I, Walker S, Williams B. Agonist-stimulated turnover of the phosphoinositides and the regulation of adrenocortical steroidogenesis. J Mol Endocrinol 1990; 5: 191-209
49. Perraudin V, Delarue C, Lefebvre H, Contesse V, Kuhn, J-M, Vaudry H. Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of V1 receptors. J Clin Endocrinol Metab 1993; 76: 1522-8
50. Gallo-Payet N, Guillon G, Balestre MN, Jard S. Vasopressin induces breakdown of membrane phosphoinositides in adrenal glomerulosa and fasciculata cells. Endocrinology 1986; 119: 1042-7
51. Balla T, Enyedi P, Spat A, Antoni FA. Pressor-type receptors in the adrenal cortex: properties of binding, effects on phosphoinositide metabolism and aldosterone secretion. Endocrinology 1985; 117: 421-3
52. Guillon G, Gallo-Payet N. Specific vasopressin binding to rat adrenal glomerulosa cells. Biochem J 1986; 235: 209-14
53. Woodcock E, McLeod J, Johnston C. Vasopressin stimulates phosphatidylinositol turnover and aldosterone synthesis in rat adrenal glomerulosa cells: comparison with angiotensin II. Endocrinology 1986; 118: 2432-6
54. Langlois D, Arroub M, Saez JM, Begeot M. Vasopressin induces breakdown of phosphoinositides in adrenal tumor Y-I cells without a steroidogenic effect. Mol cell Endocrinol 1988; 58: 199-205
55. Enyedi P, Balla T, Antoni F, Spat A. Effect of angiotensin II and arginine vasopressin on aldosterone production and phosphoinositide turnover in rat adrenal glomerulosa cells: a comparative study. J Mol Endocrinology 1988; 1: 117-24
56. Quinn S, Eneydi P, Tillotson D, Williams G: Cytosolic calcium and aldosterone response patterns of rat adrenal glomerulosa cells stimulated by vasopressin: Comparison with angiotensin II. Endocrinology 1990; 127: 541-8
57. Larcher A, Lamacz M, Delarue C, Vaudry H. Effect of vasotocin on cytosolic free calcium concentrations in frog adrenocortical cells in primary culture. Endocrinology 1992; 131: 1087-93
58. Grazzini E, Guillon G, Chouinard G, Gagnon J-S, Prezeau L, Gallo-Payet N. Dual effects of fluoroaluminate on activation of calcium influx and inhibition of agonist-induced calcium mobilization in rat glomerulosa cells. Cell Calcium 1996; 19: 29-41
59. Baukal AJ, Guillemette G, Rubin R, Spat A, Catt KJ. Binding sites for inositol trisphosphate in the bovine adrenal cortex. Biochem Biophys Res Commun 1985; 133: 532-8
60. Guillemette G, Balla T, Baukal AJ, Spat A, Catt KJ. Intracellular receptors for inositol 1,4,5-trisphosphate in angiotensin II target tissues. J Biol Chem 1987; 262: 1010-5
61. Gallo-Payet N, Chouinard L, Balestre MN, Guillon G. Involvement of protein kinase C in the coupling between the V1 vasopressin receptor and phospholipase C in rat glomerulosa cells: Effects on aldosterone secretion. Endocrinology 1991; 129: 623-34
62. 1 cells: Relation to G protein-mediated phospholipase C activation. Proc Natl Acad Sci USA 1995; 92: 8413-7
63. Guillon G, Balestre M-N, Chouinard L, Gallo-Payet N. Involvement of distinct G-proteins in the action of vasopressin of rat glomerulosa cells. Endocrinology 1990; 126: 1699-1708
64. Guillon G, Gallo-Payet N, Balestre M, Lombard C. Cholera-toxin and corticotropin modulation of inositol phosphate accumulation induced by vasopressin and angiotensin II rat glomerulosa cells. Biochem J 1988; 253: 765-75
65. Hawthorn J, Nussey SS, Henderson JR, Jenkins JS. Immunohistochemical localization of oxytocin and vasopressin in the adrenal glands of rat, cow, hamster and guinea-pig. Cell Tissue Res 1987; 250: 1-6
66. Ravid R, Oosterbaan HP, Hansen BL, Swaab DF. Localization of oxytocin, vasopressin and parts of precursors in the human neonatal adrenal. Histochemistry 1986; 84: 401-7
67. Nussey SS, Prysor-Jones RA, Taylor A, Ang VTY, Jenkins JS. Arginine vasopressin and oxytocin in the bovine adrenal gland. J Endocrinol 1987; 115: 141-9
68. Grazzini E, Loedboerer A, Perez-Martin A, Joubert D, Guillon G. Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla. Endocrinology 1996; 137: 3906-14
69. Suda T, Tomori N, Tozana F, Mouri T, Demupa H, Shizume K. Distribution and characterization of ir-CRF in human tissues. J Clin Endocrinol Metab 1984; 59: 861-7
70. Porter ID, Whitehouse BJ, Taylor AH, Nussey SS. Effect of arginine vasopressin and oxytocin on acetylcholine-stimulation of corticosteroid and catecholamine secretion from the rat adrenal gland perfused in situ. Neuropeptides 1988; 12: 265-71
71. Antoni F. Characterization of high affinity binding sites for vasopressin in bovine adrenal medulla. Neuropeptides 1984; 4: 413 -20
72. Taylor AH, St J. Whitley G, Nussey SS. The interaction of arginine vasopressin and oxytocin with bovine adrenal medulla cells. J Endocrinol 1989; 121: 133-9
73. Schwartz J, Derdowska I, Sobocinska M, Kuprysensky G. A potent new synthetic analog of vasopressin with relative agonist specificity for the pituitary. Endocrinology 1991; 129: 1107-9
74. Serradeil-Le Gal C, Wagnon J, Garcia C, Lacour C, Guiraudou P, Christophe B, Villanova G, Nizato D, Maffrand J, Le Fur G, Guillon G, Cantau B, Barberis C, Trueba M, Ala Y, Jard S. Biochemical and pharmacological properties of SR 49059, a new potent nonpeptide antagonist in rat and human vasopressin V1 a receptor. J Clin Invest 1993; 92: 224-31
75. Grazzini E, Gallo-Payet N, Chouinard L, Boccara G, Joubert D, Payet MD, Trueba M, Durroux T, Serradeil Le Gal C, Guillon G. Vasopressin regulates adrenal functions by acting through different vasopressin receptor subtypes. In: Advances in Experimental Medicine and Biology. Zingg H, editor, or. Plenum Press, 1997: in press
76. Mazzochi G, Malendowicz L, Rebuffat P, Tortorella C, Nussdorfer G. Arginine-vasopressin stimulates CRH and ACTH release by rat adrenal medulla, acting via the V1 receptor subtype and a protein kinase C-dependent pathway. Peptides 1997; 18: 191-5
77. Markowska A, Rrebuffat P, Rocco S, Gottardo G, Mazzocchi G, Nussdorfer GG. Evidence that an extra hypothalamic pituitary corticotropin-releasing hormone (CRH/adrenocorticotropin (ACTH)) system controls adrenal growth and secretion in rats. Cell Tissue Res 1993; 272: 439-45
78. Mazzocchi C, Malendowicz LK, Markowska A, Nussdorfer, G. Effect of hypophysectomy on corticotropin-releasing hormone and adrenocorticotropin immunoreactivies in the rat adrenal gland. Mol Cell Neurosc 1994; 5: 345-9
79. O'Brien T, Young WF, Davila DG, Schelthauer BW, Kovacs K, Horvath E, Vale W, Van Heerden JA. Cushing's syndrome associated with ectopic production of corticotrophin-releasing hormone, corticotrophin and vasopressin by a phaeochromocytoma. Clin endocrinol 1992; 37: 460-7
80. Perraudin V, Delarue C, De Keyzer Y. Vasopressin-responsive adrenocortical tumor cell in a mild Cushing's syndrome: in vivo and in vitro studies. J Clin Endocrinol Metab 1995; 80: 2661-7
81. Horiba N, Suda T, Aiba M, Naruse M, Nomura K, Imamura M, Demura H. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab 1995; 80: 2336-41
82. Lacroix A, Tremblay J, Touyz RM, Deng LY, Larivière R, Cusson JR, Schiffrin EL, Hamet P. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular and orthostatic hypotension. J Clin Endocrinol Metab 1997; 82: 2414-22
83. Lang V, Valloton M. Angiotensin II but not potassium induces subcellular redistribution of protein kinase C in bovine adrenal glomerulosa cells. J Biol Chem 1987; 262: 8047-50
84. Serradeil-Le Gal C, Lacour C, Valette G, Garcia G, Foulon L, Galindo G, Bankir L, Pouzet B, Guillon G, Barberis C, Chicot D, Jard S, Vilain P, Garcia C, Marty E, Raufaste D, Btrossard G, Nisato D, Maffrand J-P, Le Fur G. A highly potent and selective, orally active vasopressin V2 receptor antagonist. J Clin Invest 1996; 98: 2729-38